Fmr Llc - Aug 6, 2021 Form 4/A - Amendment Insider Report for Beam Therapeutics Inc. (BEAM)

Role
Other*, 10%+ Owner
Signature
Chris Gouveia, Duly authorized under Powers of Attorney, by and on behalf of FMR LLC and its direct and indirect subsidiaries, and Abigail P. Johnson
Stock symbol
BEAM
Transactions as of
Aug 6, 2021
Transactions value $
$0
Form type
4/A - Amendment
Date filed
8/16/2021, 05:14 PM
Date Of Original Report
Aug 10, 2021
Previous filing
Aug 4, 2021
Next filing
Aug 26, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BEAM Common Stock Other $0 -745K -10.69% $0.00 6.23M Aug 6, 2021 F-Prime Capital Partners Healthcare Fund V LP F1
transaction BEAM Common Stock Other $0 +7.45K $0.00 7.45K Aug 6, 2021 F-Prime Capital Partners Healthcare Advisors Fund V LP F1
transaction BEAM Common Stock Other $0 -7.45K -100% $0.00* 0 Aug 6, 2021 F-Prime Capital Partners Healthcare Advisors Fund V LP F1
transaction BEAM Common Stock Other $0 +724 $0.00 724 Aug 6, 2021 F-Prime Inc. F1
transaction BEAM Common Stock Other $0 +447K +62.7% $0.00 1.16M Aug 6, 2021 Impresa Fund III Limited Partnership F1
transaction BEAM Common Stock Other $0 -1.16M -99.99% $0.00 153 Aug 9, 2021 Impresa Fund III Limited Partnership F1
transaction BEAM Common Stock Other $0 +950K $0.00 950K Aug 9, 2021 Shares held by persons and entities whose shares are subject to reporting by the undersigned. F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These holdings were acquired or disposed of (as applicable) in the form of a distribution without payment of consideration.
F2 This amendment is being filed to include missing holdings from Table 1 by persons and entities whose shares are subject to reporting by the undersigned and report FMR LLC still subject to Section 16.

Remarks:

Remark 1: Abigail P. Johnson is a Director, the Chairman and the Chief Executive Officer of FMR LLC. Members of the Johnson family, including Abigail P. Johnson, are the predominant owners, directly or through trusts, of Series B voting common shares of FMR LLC, representing 49% of the voting power of FMR LLC. The Johnson family group and all other Series B shareholders have entered into a shareholders' voting agreement under which all Series B voting common shares will be voted in accordance with the majority vote of Series B voting common shares. Accordingly, through their ownership of voting common shares and the execution of the shareholders' voting agreement, members of the Johnson family may be deemed, under the Investment Company Act of 1940, to form a controlling group with respect to FMR LLC. The address of Abigail P. Johnson is c/o FMR LLC, 245 Summer Street, Boston, MA 02110. Remark 2: The filing of this statement shall not be deemed to be an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the undersigned are the beneficial owners of any securities reported herein. Remark 3: The general partner of F-Prime Capital Partners Healthcare Fund V LP is F-Prime Capital Partners Healthcare Advisors Fund V LP (FPCPHA). FPCPHA is solely managed by Impresa Management LLC, the general partner of its general partner and its investment manager. Impresa Fund III Limited Partnership is solely managed by Impresa Management LLC, its general partner and investment manager. Impresa Management LLC is owned, directly or indirectly, by various shareholders and employees of FMR LLC, including certain members of the Johnson family. F-Prime Inc. is a wholly-owned subsidiary of FMR LLC.